Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-25-097005

Options or other derivatives

  • CEO & President acquired 197,285 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cox John CEO & President 2025-07-16 Grant or award · Stock option (right to buy) +197,285 197,285 D: show line 1 in the form
Loading xslF345X05/ownership.xml…